<DOC>
	<DOCNO>NCT00058448</DOCNO>
	<brief_summary>RATIONALE : Drugs use chemotherapy docetaxel use different way stop tumor cell divide stop grow die . PURPOSE : Phase II trial study effectiveness docetaxel treat patient locally advance metastatic penile cancer .</brief_summary>
	<brief_title>S0224 , Docetaxel Treating Patients With Locally Advanced Metastatic Penile Cancer ( TERMINATED )</brief_title>
	<detailed_description>OBJECTIVES : - Determine confirm complete partial response rate patient locally advance metastatic epidermoid carcinoma penis treat docetaxel . - Determine progression-free overall survival patient treated drug . - Determine qualitative quantitative toxic effect drug patient . OUTLINE : Patients receive docetaxel IV 15-30 minute day 1 , 8 , 15 . Treatment repeat every 4 week 6 course absence disease progression unacceptable toxicity . Patients follow every 3 month 1 year every 6 month 2 year . PROJECTED ACCRUAL : A total 20-40 patient accrue study within 3-5.8 year .</detailed_description>
	<mesh_term>Penile Neoplasms</mesh_term>
	<mesh_term>Docetaxel</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Histologically confirm epidermoid carcinoma penis Distant metastases ( M1 ) OR Pathologically confirm regional nodal metastasis ( N13 ) Measurable disease Soft tissue disease irradiate within past 2 month consider measurable disease PATIENT CHARACTERISTICS : Age Not specify Performance status Zubrod 02 Life expectancy Not specify Hematopoietic White blood cell ( WBC ) count least 3,000/mm^3 Absolute granulocyte count least 1,500/mm^3 Platelet count least 100,000/mm^3 Hepatic Bilirubin great upper limit normal ( ULN ) Aspartate aminotransferase ( SGOT ) great 2.5 time ULN If SGOT great ULN , alkaline phosphatase must great 2.5 time ULN Alkaline phosphatase great 4 time ULN If alkaline phosphatase great ULN , SGOT must great 1.5 time ULN Renal Not specify Other Fertile patient must use effective contraception No malignancy within past 5 year except adequately treat basal cell squamous cell skin cancer stage I II cancer currently complete remission No grade 2 great peripheral neuropathy No hypersensitivity drug formulate polysorbate 80 ( e.g. , recombinant interferon alfa2a , multivitamin infusion , etoposide , infliximab , NovoSeven factor ) PRIOR CONCURRENT THERAPY : Biologic therapy Not specify Chemotherapy No prior chemotherapy penile cancer Endocrine therapy Not specify Radiotherapy See Disease Characteristics At least 28 day since prior radiotherapy recover Surgery Not specify</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2013</verification_date>
	<keyword>stage II penile cancer</keyword>
	<keyword>stage III penile cancer</keyword>
	<keyword>stage IV penile cancer</keyword>
</DOC>